List of Tables
Table 1. Prescription Drugs Market Trends
Table 2. Prescription Drugs Market Drivers & Opportunity
Table 3. Prescription Drugs Market Challenges
Table 4. Prescription Drugs Market Restraints
Table 5. Global Prescription Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Prescription Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Prescription Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Prescription Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Prescription Drugs
Table 10. Global Prescription Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Prescription Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Prescription Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Prescription Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Prescription Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Prescription Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Prescription Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Prescription Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Prescription Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Prescription Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Prescription Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Prescription Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Prescription Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Prescription Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Prescription Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Prescription Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Prescription Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Prescription Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Prescription Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. Pfizer Basic Information List
Table 32. Pfizer Description and Business Overview
Table 33. Pfizer Prescription Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Prescription Drugs Business of Pfizer (2019-2024)
Table 35. Pfizer Recent Developments
Table 36. Roche Basic Information List
Table 37. Roche Description and Business Overview
Table 38. Roche Prescription Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Prescription Drugs Business of Roche (2019-2024)
Table 40. Roche Recent Developments
Table 41. Sanofi Basic Information List
Table 42. Sanofi Description and Business Overview
Table 43. Sanofi Prescription Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Prescription Drugs Business of Sanofi (2019-2024)
Table 45. Sanofi Recent Developments
Table 46. Johnson & Johnson Basic Information List
Table 47. Johnson & Johnson Description and Business Overview
Table 48. Johnson & Johnson Prescription Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Prescription Drugs Business of Johnson & Johnson (2019-2024)
Table 50. Johnson & Johnson Recent Developments
Table 51. Merck & Co. (MSD) Basic Information List
Table 52. Merck & Co. (MSD) Description and Business Overview
Table 53. Merck & Co. (MSD) Prescription Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Prescription Drugs Business of Merck & Co. (MSD) (2019-2024)
Table 55. Merck & Co. (MSD) Recent Developments
Table 56. Novartis Basic Information List
Table 57. Novartis Description and Business Overview
Table 58. Novartis Prescription Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Prescription Drugs Business of Novartis (2019-2024)
Table 60. Novartis Recent Developments
Table 61. AbbVie Basic Information List
Table 62. AbbVie Description and Business Overview
Table 63. AbbVie Prescription Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Prescription Drugs Business of AbbVie (2019-2024)
Table 65. AbbVie Recent Developments
Table 66. Gilead Sciences Basic Information List
Table 67. Gilead Sciences Description and Business Overview
Table 68. Gilead Sciences Prescription Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Prescription Drugs Business of Gilead Sciences (2019-2024)
Table 70. Gilead Sciences Recent Developments
Table 71. GlaxoSmithKline (GSK) Basic Information List
Table 72. GlaxoSmithKline (GSK) Description and Business Overview
Table 73. GlaxoSmithKline (GSK) Prescription Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Prescription Drugs Business of GlaxoSmithKline (GSK) (2019-2024)
Table 75. GlaxoSmithKline (GSK) Recent Developments
Table 76. Amgen Basic Information List
Table 77. Amgen Description and Business Overview
Table 78. Amgen Prescription Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Prescription Drugs Business of Amgen (2019-2024)
Table 80. Amgen Recent Developments
Table 81. AstraZeneca Basic Information List
Table 82. AstraZeneca Description and Business Overview
Table 83. AstraZeneca Prescription Drugs Products, Services and Solutions
Table 84. Revenue (US$ Million) in Prescription Drugs Business of AstraZeneca (2019-2024)
Table 85. AstraZeneca Recent Developments
Table 86. Bristol-Myers Squibb Basic Information List
Table 87. Bristol-Myers Squibb Description and Business Overview
Table 88. Bristol-Myers Squibb Prescription Drugs Products, Services and Solutions
Table 89. Revenue (US$ Million) in Prescription Drugs Business of Bristol-Myers Squibb (2019-2024)
Table 90. Bristol-Myers Squibb Recent Developments
Table 91. Eli Lilly Basic Information List
Table 92. Eli Lilly Description and Business Overview
Table 93. Eli Lilly Prescription Drugs Products, Services and Solutions
Table 94. Revenue (US$ Million) in Prescription Drugs Business of Eli Lilly (2019-2024)
Table 95. Eli Lilly Recent Developments
Table 96. Teva Basic Information List
Table 97. Teva Description and Business Overview
Table 98. Teva Prescription Drugs Products, Services and Solutions
Table 99. Revenue (US$ Million) in Prescription Drugs Business of Teva (2019-2024)
Table 100. Teva Recent Developments
Table 101. Bayer Basic Information List
Table 102. Bayer Description and Business Overview
Table 103. Bayer Prescription Drugs Products, Services and Solutions
Table 104. Revenue (US$ Million) in Prescription Drugs Business of Bayer (2019-2024)
Table 105. Bayer Recent Developments
Table 106. Novo Nordisk Basic Information List
Table 107. Novo Nordisk Description and Business Overview
Table 108. Novo Nordisk Prescription Drugs Products, Services and Solutions
Table 109. Revenue (US$ Million) in Prescription Drugs Business of Novo Nordisk (2019-2024)
Table 110. Novo Nordisk Recent Developments
Table 111. AbbVie Basic Information List
Table 112. AbbVie Description and Business Overview
Table 113. AbbVie Prescription Drugs Products, Services and Solutions
Table 114. Revenue (US$ Million) in Prescription Drugs Business of AbbVie (2019-2024)
Table 115. AbbVie Recent Developments
Table 116. Takeda Basic Information List
Table 117. Takeda Description and Business Overview
Table 118. Takeda Prescription Drugs Products, Services and Solutions
Table 119. Revenue (US$ Million) in Prescription Drugs Business of Takeda (2019-2024)
Table 120. Takeda Recent Developments
Table 121. Boehringer Ingelheim Basic Information List
Table 122. Boehringer Ingelheim Description and Business Overview
Table 123. Boehringer Ingelheim Prescription Drugs Products, Services and Solutions
Table 124. Revenue (US$ Million) in Prescription Drugs Business of Boehringer Ingelheim (2019-2024)
Table 125. Boehringer Ingelheim Recent Developments
Table 126. Takeda Basic Information List
Table 127. Takeda Description and Business Overview
Table 128. Takeda Prescription Drugs Products, Services and Solutions
Table 129. Revenue (US$ Million) in Prescription Drugs Business of Takeda (2019-2024)
Table 130. Takeda Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Prescription Drugs Downstream Customers
Table 134. Prescription Drugs Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Prescription Drugs Product Picture
Figure 2. Global Prescription Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Prescription Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Prescription Drugs Report Years Considered
Figure 5. Global Prescription Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Prescription Drugs Revenue in 2023
Figure 7. Prescription Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Brand Drugs Picture
Figure 9. Generic Drug Picture
Figure 10. Global Prescription Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Prescription Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospital
Figure 13. Product Picture of Clinic
Figure 14. Product Picture of Other
Figure 15. Global Prescription Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Prescription Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Prescription Drugs Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Prescription Drugs Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Prescription Drugs Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Prescription Drugs Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Prescription Drugs Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Prescription Drugs Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Prescription Drugs Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Prescription Drugs Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Prescription Drugs Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Prescription Drugs Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Prescription Drugs Sales Value (%), (2019-2030)
Figure 28. United States Prescription Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Prescription Drugs Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Prescription Drugs Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Prescription Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Prescription Drugs Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Prescription Drugs Sales Value by Application (%), 2023 VS 2030
Figure 34. China Prescription Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Prescription Drugs Sales Value by Type (%), 2023 VS 2030
Figure 36. China Prescription Drugs Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Prescription Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Prescription Drugs Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Prescription Drugs Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Prescription Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Prescription Drugs Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Prescription Drugs Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Prescription Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Prescription Drugs Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Prescription Drugs Sales Value by Application (%), 2023 VS 2030
Figure 46. India Prescription Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Prescription Drugs Sales Value by Type (%), 2023 VS 2030
Figure 48. India Prescription Drugs Sales Value by Application (%), 2023 VS 2030
Figure 49. Prescription Drugs Industrial Chain
Figure 50. Prescription Drugs Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
